James R. Largent - 02 Nov 2021 Form 4 Insider Report for ALIMERA SCIENCES INC

Role
Director
Signature
/s/ James R. Largent
Issuer symbol
N/A
Transactions as of
02 Nov 2021
Net transactions value
+$43,090
Form type
4
Filing time
04 Nov 2021, 20:09:49 UTC
Next filing
06 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALIM Common Stock Purchase $43,090 +10,000 +333% $4.31 13,000 03 Nov 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALIM Stock Option (Right to Buy) Award $0 +6,000 $0.000000 6,000 02 Nov 2021 Common Stock 6,000 $4.05 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.11 to $4.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2 Vests in full on June 15, 2022, provided the Reporting Person provides continuous service to the Issuer through such date.